ABSI is currently sitting on a 35M share short position (roughly 26% of the float) with a massive 12-day-to-cover lead. Morgan Stanley just tried to bury it with a $4.32 price target after the pivot to the ABS-201 hair-loss drug, yet the Feb 20th options chain is showing a ridiculous amount of Call Open Interest at the $3, $4, and $5 strikes compared to almost zero Put activity.
With the Origin-1 AI model hype coming out of JPM and prediction markets like Polymarket pricing in massive volatility for AI-drug discovery through Q1, this feels like a massive gamma setup hiding in plain sight. Are we looking at a coordinated institutional hedge, or is the "AI hair-loss cure" actually about to squeeze the shorts into orbit? Curious if anyone has the tape on who is size-buying these calls.